Papadaki et al. described augmented serum levels of IL-6 and soluble IL-6 receptor (sIL-6R) in 48% of subjects with MM, while normal sIL-6R levels were described in a greater number of subjects with MGUS [117]. This evidence concerns the gene IL6 and Miyoshi myopathy.